13 found
Order:
  1.  14
    Clarifying the Relationship Between Serious Ethical Violations and Conflicts of Interest.Ian Kerridge, Narcyz Ghinea & Wendy Lipworth - 2019 - American Journal of Bioethics 19 (1):48-50.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  2.  15
    Citizen Science and the Politicization of Epistemology.Narcyz Ghinea - 2019 - American Journal of Bioethics 19 (8):58-60.
    Volume 19, Issue 8, August 2019, Page 58-60.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3.  18
    Overcoming Entrenched Disagreements: The Case of Misoprostol for Post‐Partum Haemorrhage.Narcyz Ghinea, Wendy Lipworth, Miles Little, Ian Kerridge & Richard Day - 2015 - Developing World Bioethics 15 (1):48-54.
    The debate about whether misoprostol should be distributed to low resource communities to prevent post-partum haemorrhage, recognised as a major cause of maternal mortality, is deeply polarised. This is in spite of stakeholders having access to the same evidence about the risks and benefits of misoprostol. To understand the disagreement, we conducted a qualitative analysis of the values underpinning debates surrounding community distribution of misoprostol. We found that different moral priorities, epistemic values, and attitudes towards uncertainty were the main factors (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  4.  4
    Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?Narcyz Ghinea, Wendy Lipworth & Ian Kerridge - 2020 - Journal of Bioethical Inquiry 17 (1):87-94.
    Consumer engagement in decisions about the funding of medicines is often framed as a good in and of itself and as an activity that should be universally encouraged. A common justification for calls for consumer engagement is that it enhances equity. In this paper we systematically critique this assumption. We show that consumer engagement may undermine equity as well as enhance it and show that a simple relationship cannot be assumed but must be justified and demonstrated. In concluding, we present (...)
    Direct download (2 more)  
    Translate
     
     
    Export citation  
     
    Bookmark   1 citation  
  5.  3
    Lead Essay: Money, Equity and Access to Medicines.Narcyz Ghinea, Wendy Lipworth & Ian Kerridge - 2020 - Journal of Bioethical Inquiry 17 (1):25-27.
    Direct download (2 more)  
    Translate
     
     
    Export citation  
     
    Bookmark   1 citation  
  6.  25
    Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake.Narcyz Ghinea, Miles Little & Wendy Lipworth - 2017 - Journal of Bioethical Inquiry 14 (3):401-410.
    Cancer is a major burden on populations and health systems internationally. The development of innovative cancer medicines is seen as a significant part of the solution. These new cancer medicines are, however, expensive, leading to limited or delayed access and disagreements among stakeholders about which medicines to fund. There is no obvious resolution to these disagreements, with stakeholders holding firmly to divergent positions. Access to cancer medicines was recently explored in Australia in a Senate Inquiry into the Availability of New, (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  3
    A Return to Reasonableness and Virtue in Medical Epistemology.Narcyz Ghinea - 2020 - Journal of Evaluation in Clinical Practice 26 (2):447-451.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  11
    Evidence, Regulation and ‘Rational’ Prescribing: The Case of Gabapentin for Neuropathic Pain.Narcyz Ghinea, Wendy Lipworth & Ian Kerridge - 2015 - Journal of Evaluation in Clinical Practice 21 (1):28-33.
  9.  13
    Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII.Narcyz Ghinea, Wendy Lipworth, Ian Kerridge, Miles Little & Richard O. Day - 2014 - Hastings Center Report 44 (2):38-45.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  10.  2
    Are My Religious Beliefs Anyone’s Business? A Framework for Declarations in Health and Biomedicine.Narcyz Ghinea, Miriam Wiersma, Ian Kerridge & Wendy Lipworth - forthcoming - Journal of Medical Ethics:medethics-2020-106087.
    Conflicts of interests are typically divided into those that are financial and those that are not. While there is general agreement that financial COIs have a significant impact on decisions and need to be declared and managed, the status of non-financial COIs continues to be disputed. In a recent BMJ feature article it was proposed that religious beliefs should be routinely declared as an interest. The article generated over 41 responses from the medical community and health researchers, which put forward (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  11.  11
    Challenges to the Validity of Using Medicine Labels to Categorize Clinical Behavior: An Empirical and Normative Critique of “Off-Label” Prescribing.Narcyz Ghinea, Ian Kerridge, Miles Little & Wendy Lipworth - 2017 - Journal of Evaluation in Clinical Practice 23 (3):574-581.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  12.  7
    “Some Sort of Fantasy Land”: A Qualitative Investigation of Appropriate Prescribing in Cancer Care.Narcyz Ghinea, Miriam Wiersma, Ian Kerridge, Ian Olver, Sallie Pearson, Richard Day, Winston Liauw & Wendy Lipworth - 2020 - Journal of Evaluation in Clinical Practice 26 (3):747-754.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  13.  10
    Limiting Religious Contributions – a Response to Schuklenk.Miriam Wiersma, Narcyz Ghinea & Wendy Lipworth - 2019 - Developing World Bioethics 19 (3):126-127.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark